Labarai

Ƙasa ba za ta iya yin haɗari ga tsofaffi ta hanyar shakatawa da manufofin COVID

By ZHANG ZHIHAO | CHINA KULLUM | An sabunta: 2022-05-16 07:39

Wani dattijo mazaunin wurin an duba hawan jininsa kafin a yi masa allurarMaganin rigakafin cutar covid-19a gida a gundumar Dongcheng na birnin Beijing, 10 ga Mayu, 2022. [Hoto/Xinhua]

Ingantacciyar ɗaukar hoto ga tsofaffi, ingantaccen sarrafa sabbin maganganu da albarkatun kiwon lafiya, ingantaccen gwaji da isa, da kuma jiyya a gida don COVID-19 wasu mahimman abubuwan da ake buƙata don China don daidaita manufofinta na yanzu don sarrafa COVID, babban ƙwararrun cututtukan cututtuka. yace.

Idan ba tare da waɗannan sharuɗɗa ba, yin aiki mai ƙarfi ya kasance mafi kyawu kuma dabarun da ke da alhaki ga kasar Sin, saboda kasar ba za ta iya yin kasada da rayukan manyan al'ummarta ba ta hanyar sassauta matakan rigakafin cutar da wuri, in ji Wang Guiqiang, shugaban sashen cututtukan cututtuka na asibitin farko na jami'ar Peking. .

Babban yankin kasar Sin ya ba da rahoton bullar cutar COVID-19 guda 226 da aka tabbatar a gida a ranar Asabar, wadanda 166 daga cikinsu suna Shanghai, 33 kuma a nan birnin Beijing, a cewar rahoton hukumar lafiya ta kasar a ranar Lahadi.

A wani taron karawa juna sani na jama'a a ranar Asabar, Wang, kuma memba na kungiyar kwararru ta kasa kan kula da lamuran COVID-19, ya ce barkewar COVID-19 na baya-bayan nan a Hong Kong da Shanghai sun nuna cewa bambancin Omicron na iya haifar da babbar barazana ga tsofaffi, musamman waɗanda ba a yi musu allurar rigakafi ba kuma suna da yanayin rashin lafiya.

"Idan kasar Sin tana son sake budewa, abin da ake bukata na 1 shi ne rage yawan mutuwar barkewar COVID-19, kuma hanya mafi kyau don yin hakan ita ce ta hanyar rigakafi," in ji shi.

Alkaluman kiwon lafiyar jama'a na yankin musamman na Hong Kong sun nuna cewa ya zuwa ranar Asabar, adadin wadanda suka kamu da cutar ta Omicron ya kai kashi 0.77 cikin dari, amma adadin ya karu zuwa kashi 2.26 na wadanda ba a yi musu allurar ba ko kuma wadanda ba su kammala allurar ba.

Kimanin mutane 9,147 ne suka mutu a sabuwar barkewar cutar a birnin har zuwa ranar Asabar, mafi yawansu tsofaffi masu shekaru 60 da haihuwa. Ga wadanda suka haura shekaru 80, yawan mace-macen ya kasance kashi 13.39 idan ba su samu ko kammala allurar rigakafinsu ba.

Hukumar lafiya ta kasar ta ce, ya zuwa ranar alhamis, sama da tsofaffi miliyan 228 da suka haura shekaru 60 a yankin kasar Sin, an yi musu allurar rigakafin, wadanda miliyan 216 daga cikinsu sun kammala aikin rigakafin, kuma kimanin tsofaffi miliyan 164 ne suka samu allurar rigakafin cutar. Kasar Sin tana da kusan mutane miliyan 264 a cikin wannan rukunin har zuwa Nuwamba 2020.

Kariya mai mahimmanci

Wang ya ce, "Fadada allurar rigakafi da ɗaukar hoto ga tsofaffi, musamman waɗanda suka haura shekaru 80, yana da matuƙar mahimmanci don kare su daga mummunan cututtuka da mutuwa," in ji Wang.

Kasar Sin ta riga ta samar da alluran rigakafin da aka tsara musamman don bambancin Omicron mai saurin yaduwa. A farkon wannan watan, rukunin fasahar kere kere ta kasar Sin, wani reshen Sinopharm, ya fara gwajin asibiti don yin rigakafin cutar Omicron a Hangzhou, lardin Zhejiang.

Tunda kariyar rigakafin cutar sankara na iya raguwa na tsawon lokaci, yana da yuwuwa kuma ya zama dole mutane, gami da wadanda suka sami harbin kara kuzari a baya, su sake samun karfin rigakafinsu da allurar Omicron da zarar ta fito, in ji Wang.

Baya ga allurar rigakafi, Wang ya ce yana da matukar muhimmanci a sami ingantacciyar hanyar mayar da martani ga barkewar COVID-19 don kiyaye tsarin kiwon lafiyar kasar.

Misali, ya kamata a samar da cikakkun dokoki kan wane da kuma yadda ya kamata a kebe mutane a gida ta yadda ma’aikatan al’umma za su iya sarrafa da kuma yi wa jama’ar da aka kebe hidima yadda ya kamata, kuma don kada asibitoci su cika da kwararowar masu dauke da cutar.

"Yana da mahimmanci cewa asibitoci za su iya ba da mahimman sabis na likita ga sauran marasa lafiya yayin barkewar COVID-19. Idan wannan aiki ya tarwatse da tarin sabbin marasa lafiya, zai iya haifar da asarar rayuka a kaikaice, wanda ba za a amince da shi ba,” inji shi.

Ya kuma kamata ma’aikatan al’umma su rika lura da matsayin tsofaffi da wadanda ke da bukatu na musamman a keɓe, don haka ma’aikatan kiwon lafiya za su iya ba da taimakon jinya cikin gaggawa idan an buƙata, in ji shi.

Bugu da kari, jama'a za su bukaci karin araha da hanyoyin magance cutar, in ji Wang. Maganin rigakafin ƙwayoyin cuta na monoclonal na yanzu yana buƙatar allurar ta jijiya a cikin saitin asibiti, kuma Pfizer's COVID kwaya Paxlovid yana da ƙima mai ƙima na yuan 2,300 ($ 338.7).

"Ina fatan karin magungunan mu, da magungunan gargajiya na kasar Sin, za su iya taka rawa sosai wajen yaki da annobar," in ji shi. "Idan muna da damar samun magani mai ƙarfi kuma mai araha, to za mu sami kwarin gwiwar sake buɗewa."

Muhimman abubuwan da ake bukata

A halin da ake ciki, inganta sahihancin hanzarin na'urorin gwajin kai-da-kai na antigen da kuma faɗaɗa samun damar gwajin ƙwayoyin acid na nucleic da iya aiki a matakin al'umma su ma muhimman abubuwan da ake buƙata don sake buɗewa, in ji Wang.

"Gaba ɗaya magana, yanzu ba lokacin da China za ta sake buɗewa ba. A sakamakon haka, muna bukatar mu kiyaye dabarun kawar da kai tare da kare tsofaffi tare da matsalolin kiwon lafiya, "in ji shi.

Lei Zhenglong, mataimakiyar daraktan hukumar kula da rigakafin cututtuka ta hukumar kiwon lafiya ta kasa, ta sake nanata a ranar Jumma'a cewa, bayan yakar cutar ta COVID-19 sama da shekaru biyu, dabarun kawar da kai sun tabbatar da yin tasiri wajen kare lafiyar jama'a, kuma yana da inganci. mafi kyawun zaɓi ga kasar Sin idan aka yi la'akari da halin da ake ciki.